BCL-2 Inhibitor and Conventional Chemotherapy Combinations for Acute Myeloid Leukemia: Shifting From the Unfit to the Fit Patient With AML

Gert Ossenkoppele, Paresh Vyas

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)3461-3463
Number of pages3
JournalJournal of Clinical Oncology
Issue number30
Publication statusPublished - 20 Oct 2020

Cite this